Get more replies from employers
Send a job-specific resume in minutes.
Group Lead R&D (Associate Director Level) in Guildford leads translational biomarker programs and oversees biomarker assay development, with a focus on oncology diagnostics. This role combines scientific strategy, lab management, and cross-functional collaboration with commercial and quality teams to drive clinical translation.
You will mentor scientists, shape experimental plans, and ensure robust validation of novel assays from concept to clinical deployment, reporting to the CSO in a dynamic
You are an experienced scientific leader with a track record of building and leading high-performing R&D teams.
You are looking for a role where you can influence scientific strategy, mentor scientists, work cross-functionally with commercial and quality teams, and drive innovation from concept through to clinical implementation.
Our client, is a precision oncology company developing advanced liquid biopsy and biomarker technologies that support translational research, pharmaceutical partnerships, and clinical diagnostics. The organisation operates at the cutting edge of rare-cell analysis, molecular profiling, and imaging-based diagnostics, helping advance personalised cancer care.
As Group Lead R&D (Associate Director Level), you will provide both scientific and operational leadership across the R&D laboratories, managing day-to-day activities while driving the development and validation of novel biomarker assays.
This is a highly visible leadership role reporting to the Chief Scientific Officer, combining scientific strategy, laboratory management, assay development, and team leadership. You will be responsible for ensuring the successful translation of innovative oncology biomarkers into robust, clinically relevant assays suitable for commercial and diagnostic deployment.
You will likely bring:
Location: Guildford (5 days onsite)
Reporting To: Chief Scientific Officer
Sector: Oncology Diagnostics / Precision Medicine / Liquid Biopsy
If you're excited by the opportunity to lead a talented scientific team while developing the next generation of oncology biomarker assays, we'd love to hear from you.